Compounds > emtricitabine
Page last updated: 2024-08-24

emtricitabine and fluorexon

emtricitabine has been researched along with fluorexon in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bousquet, L; Didier, N; Farinotti, R; Mabondzo, A; Pruvost, A1
Bousquet, L; Farinotti, R; Guyot, AC; Mabondzo, A; Pruvost, A1

Other Studies

2 other study(ies) available for emtricitabine and fluorexon

ArticleYear
Emtricitabine: Inhibitor and substrate of multidrug resistance associated protein.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2008, Nov-15, Volume: 35, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromatography, Liquid; Deoxycytidine; Emtricitabine; Flow Cytometry; Fluoresceins; Humans; Mass Spectrometry; Multidrug Resistance-Associated Proteins; Neutrophils; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vincristine

2008
Combination of tenofovir and emtricitabine plus efavirenz: in vitro modulation of ABC transporter and intracellular drug accumulation.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Adenine; Alkynes; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Benzoxazines; Cells, Cultured; Cyclopropanes; Deoxycytidine; Drug Interactions; Drug Therapy, Combination; Emtricitabine; Fluoresceins; Fluorescent Dyes; Humans; Leukocytes, Mononuclear; Organophosphonates; RNA, Messenger; Tenofovir; Time Factors

2009